Phase 3 trial results show levacetylleucine improves SARA scores in patients with the rare disorder ataxia-telangiectasia.

To land on the right foot on the Red Planet, European engineers have been dropping a skeleton of the four-legged ExoMars ...

If approved, levacetylleucine could become the first therapy on the market for ataxia-telangiectasia.

Four-time Paralympic medalist Brenna Huckaby shared how family support and finding happiness matter most ahead of her third ...

While the story of the hairy leg in The Secret Agent might seem too wild to be true, it's actually based in reality.

This ancient, leg-bearing snake is rewriting the story of how serpents slithered, and sometimes walked, their way through evolutionary history.

MELBOURNE, Australia (AP) — Helping her opponent Marina Stakusic leave court in a wheelchair wasn't how Priscilla Hon ...

A common diabetes medication does not help people with peripheral artery disease (PAD) and without diabetes walk farther, ...

THE DVLA’S full list of medical conditions that could affect your legal right to drive have been revealed. The Driver and ...

PIP is broken down into two parts with daily living starting at £73.90 for the lower rate, rising to £110.40 for higher ...

Researchers from Carnegie Mellon University have discovered a way to target RNA that could lead to new treatment options for myotonic dystrophy type 1 (DM1), the most common adult-onset form of ...